# Semaglutide Discontinuation for Side Effects: 2.62 Times Placebo in Four Trials

Four trials compared injected semaglutide and placebo for weight loss and adverse-event discontinuation in adults without type 2 diabetes.

Publisher: Buy This GLP Editorial Team
Canonical: https://buythisglp.com/research/semaglutide-weight-and-dropouts
Updated: 2026-11-15
Published: 2026-09-16

[← Research](https://buythisglp.com/research)

Evidence

# Semaglutide Discontinuation for Side Effects: 2.62 Times Placebo in Four Trials

In four trials, injected semaglutide produced more weight loss than placebo. Stopping because of adverse events was also more frequent.

Editorial profile: [Neil Sanders](https://buythisglp.com/authors/neil-sanders)[Buy This GLP Editorial Team](https://buythisglp.com/about)September 20265 min readUpdated November 2026

Stopping because of side effects, vs placebo · 1× · 2.62× · 1.70 · 4.03 · Relative risk and 95% confidence interval · Four trials, 3,613 participants, none with type 2 diabetes

**Research, not medical advice.** Buy This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://buythisglp.com/methodology) and [terms](https://buythisglp.com/terms).

When comparing [GLP-1 side effects](https://buythisglp.com/research/what-are-the-side-effects-of-a-glp1), it helps to separate any reported symptom from adverse events that led participants to stop treatment. This review pooled four randomized trials of injected semaglutide [\[1\]](https://buythisglp.com/research/semaglutide-weight-and-dropouts#ref-1).

## Weight loss and stopping treatment

The trials included 3,613 adults with overweight or obesity without type 2 diabetes. The pooled difference in weight change was 11.85 percentage points in favor of semaglutide (95% CI 10.90 to 12.81 points) [\[1\]](https://buythisglp.com/research/semaglutide-weight-and-dropouts#ref-1).

Discontinuation due to adverse events was more frequent on semaglutide (risk ratio 2.62, 95% CI 1.70 to 4.03). Digestive events included nausea, vomiting, diarrhea and constipation. The review's Table 5 shows the event counts for each trial.

## How the trial result applies to routine care

Studies of [GLP-1 persistence in routine care](https://buythisglp.com/research/how-long-do-people-stay-on-a-glp1) also capture reasons such as cost and access. The trial estimate isolates discontinuations attributed to adverse events.

A relative risk compares groups and cannot predict an individual's chance of stopping. The trials also differ in how they enrolled participants and followed them.

## Frequently asked

How much more often did people stop because of adverse events?

The pooled relative risk was 2.62. The estimate compares semaglutide with placebo across the four trials.

## Sources

1.  \[1\] Naz F, et al. (2026). Effectiveness & safety of semaglutide in weight reduction in obese nondiabetic patients: A systematic review and meta-analysis Medicine. [PMID 42536519](https://pmc.ncbi.nlm.nih.gov/articles/PMC13433015/)

## Where to get it

### Price the injectable sellers

The desk lists every seller that publishes an injectable figure, with the advertised price struck against the one a buyer is billed.

[Open the price desk →](https://buythisglp.com/)

## More in Evidence

-   [
    
    50,678 adults with a BMI of 30 or more · Prescribed · 8.0% · Filled · 4.4% · Outlined bar runs to 10%. Medicaid had lower odds of both.
    
    ### Does Medicaid Cover Weight Loss Drugs? It Depends on Your State
    
    ](https://buythisglp.com/research/does-medicaid-cover-weight-loss-drugs)
-   [
    
    What the claim rests on · Sleep study · AHI 15 or more · Obesity · BMI 30 or more · Prescription · for sleep apnea · Part D claim · plan review · Trial thresholds shown. Your plan sets its approval requirements.
    
    ### Does Medicare Cover Zepbound for Sleep Apnea? The Diagnosis Is the Key
    
    ](https://buythisglp.com/research/does-medicare-cover-zepbound-for-sleep-apnea)
-   [
    
    Illustrative decline with a one-week half-life · Ozempic window: up to 5 days late · 100% · day 0 · 82% · day 2 · 67% · day 4 · 61% · day 5 · 50% · day 7 · A calculation from the label half-life, not a blood test.
    
    ### What Happens If You Miss a Dose of Ozempic? A Week-Long Half-Life Buys Time
    
    ](https://buythisglp.com/research/what-happens-if-you-miss-a-dose-of-ozempic)
